Krystal Biotech buy Chardan Capital
Start price
07.05.25
/
50%
€116.70
Target price
07.05.26
€193.05
Performance (%)
19.41%
Price
19.09.25
€139.35
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 19.41%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 13.709% | 13.709% |
| iShares Core DAX® | -0.234% | -2.812% |
| iShares Nasdaq 100 | 2.073% | 4.380% |
| iShares Nikkei 225® | 1.244% | 3.620% |
| iShares S&P 500 | 1.133% | 3.104% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€118.80
05.08.25
05.08.25
€189.46
05.08.26
05.08.26
17.30%
19.09.25
19.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€125.75
25.07.25
25.07.25
€186.52
25.07.26
25.07.26
10.82%
19.09.25
19.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-19.10%
19.09.25
19.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-8.26%
19.09.25
19.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-15.98%
19.09.25
19.09.25